MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹7,420 Cr | ₹187 Cr | ₹199 Cr | ₹169 Cr | ₹107 Cr |
What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹7,420 Cr |
| Mar2024 | ₹187 Cr |
| Mar2023 | ₹199 Cr |
| Mar2022 | ₹169 Cr |
| Mar2021 | ₹107 Cr |
How is Total Non-Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,420 Cr | 3,860.66 | |
| Mar2024 | ₹187 Cr | -5.97 | |
| Mar2023 | ₹199 Cr | 18.12 | |
| Mar2022 | ₹169 Cr | 57.15 | |
| Mar2021 | ₹107 Cr | - | |
Compare Total Non-Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹98,746.2 Cr | 0.8% | -1.5% | 0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 0.8% |
-1.5% |
0.3% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses